You may be surprised to hear it but there are new guidelines which have been laid out by NICE which have led to NHS England approving two cannabis-based medications for the treatment of epilepsy and multiple sclerosis (MS). Children who experience highly severe forms of epilepsy, Lennox Gastaut syndrome and Dravet syndrome will now be able to receive Epidyolex while UK residents who are living with MS can now get Sativex for the relief of spasticity that they may be experiencing.
The CMC stated its new report, CBD in the UK there that has been a real shift towards a responsible, innovative and high-quality cannabidiol industry after conducting the most comprehensive review that has ever been carried out by of this sector in the UK.
Market research commissioned by the CMC estimates that the CBD market is currently one of the fastest-growing wellbeing product categories in the UK. At the current rate, it will be worth almost one billion per annum by 2025 and this is estimated to be the equivalent in size to the current entire UK herbal supplement market.
What can the drugs be used to treat?
One of these drugs know as Epidyolex, has been prescribed to children with two strands of severe epilepsy (Lennox Gastaut syndrome and Dravet syndrome) which can both result in multiple seizures in one single day. There are an estimated 3,000 people in the UK with Dravet and around 5,000 with Lennox Gastaut syndrome who would no doubt benefit from CBD treatment.
An oral solution, which contains the cannabidiol (CBD), can decrease the number of seizures by around 40 per cent in young children, this in accordance with evidence provided by medical trials. It does not contain THC, which is the psychoactive component present in cannabis.
The overall positive impact of CBD and how it has shown to be life-transforming for a significant number of children, including those involved in the high-profile cases of last year which led to medical cannabis being legalised. It is estimated that with evidence shown in recent studies that cannabis-based treatments could help about 10,000 people with MS.
The families of two British children, Billy Caldwell and Alfie Dingley, both of whom have experienced severe epilepsy, have campaigned repeatedly for easier access to cannabis-based medicines in the UK, something that seems to be on the horizon much to the delight of many people who experience health problems or otherwise.
Here at Little Rick Drinks, we take inspiration from the world’s favourite cocktails, reinventing them with one subtle twist: they’re alcohol-free. Instead of alcohol, each drink is infused with cannabidiol, cannabigerol and cannabichromene to create a truly relaxing effect. To find out more and for your first taste of pure relaxation, browse our selection of Little Rick drinks on our website or order wholesale from our online shop. Choose between Mint & Lime, Raspberry Coconut or Piña and see how good it feels to unwind today!